Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.79 USD | -1.33% | +5.55% | -12.60% |
07/05 | Beam Therapeutics Shares Fall After Q1 Revenue Misses Estimates | MT |
07/05 | Beam Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.60% | 190.25Cr | |
+33.37% | 4.95TCr | |
+1.55% | 4.26TCr | |
+49.11% | 4.25TCr | |
-4.22% | 2.91TCr | |
+11.57% | 2.66TCr | |
-21.00% | 1.86TCr | |
+7.36% | 1.32TCr | |
+28.30% | 1.25TCr | |
+23.80% | 1.21TCr |
- Stock Market
- Equities
- BEAM Stock
- News Beam Therapeutics Inc.
- Citigroup Adjusts Beam Therapeutics Price Target to $56 From $60, Maintains Buy Rating